MARK1 and hepatocellular carcinoma: Luciferase reporter assay verified that MARK1 can directly bind to its target gene POTEE, and we demonstrated that overexpression of POTEE could reverse the suppressing influence of overexpression of MARK on the proliferative ability of sorafenib-resistant HCC cells.